Skip to main content

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

RESSTORE: REgenerative Stem cell therapy for STroke in Europe GA No 681044

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla
Funding agency: EUROPEAN COMMISSION
Funding: 350000
Reference: RESSTORE_H2020-PHC2015
Duration: 01/09/2015 - 08/11/2018

STROKE BIO-TARGETS: Nuevas estrategias para descubrir biomarcadores de isquemia cerebral y su aplicación como dianas terapéuticas en el ictus

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla
Funding agency: Instituto de Salud Carlos III
Funding: 272552.5
Reference: PI15/00354
Duration: 01/01/2016 - 31/12/2018

"Dispositivo Point of Care de Diagnóstico del Ictus mediante Biomarcadores Plasmáticos: 2-Stroke-Chip".

IP: Joan Montaner Villalonga
Collaborators: Bustamante Rangel, Alejandro, Eva Baldrich Rubio, Anna Penalba Morenilla
Funding agency: Instituto de Salud Carlos III
Funding: 155650
Reference: DTS14/00004
Duration: 01/01/2015 - 31/12/2016

Malalties Neurovasculars (GRC)

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Bustamante Rangel, Alejandro, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Yolanda Riba Llena, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 48000
Reference: 2014 SGR 686
Duration: 01/01/2014 - 31/12/2016

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Josep Paunellas Albert

Josep Paunellas Albert

Shock, Organ Dysfunction and Resuscitation
Read more
Alejandro Balleste Nadal

Alejandro Balleste Nadal

Research assistant
Cardiovascular Diseases
Read more
Antonio Alvarez Gonzalez

Antonio Alvarez Gonzalez

Shock, Organ Dysfunction and Resuscitation
Read more
Judit Amigó Farran

Judit Amigó Farran

Predoctoral researcher
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.